HealthCor Management, L.P. - Q2 2022 holdings

$995 Million is the total value of HealthCor Management, L.P.'s 58 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 136.4% .

 Value Shares↓ Weighting
BIIB BuyBIOGEN INC$84,358,000
-0.3%
413,640
+3.0%
8.48%
+50.2%
HZNP BuyHORIZON THERAPEUTICS PUB L$72,091,000
-3.5%
903,850
+27.3%
7.24%
+45.4%
HOLX NewHOLOGIC INC$27,866,000402,110
+100.0%
2.80%
THC BuyTENET HEALTHCARE CORP$27,278,000
+11.8%
518,990
+82.9%
2.74%
+68.5%
CCXI BuyCHEMOCENTRYX INC$27,193,000
+13.4%
1,097,370
+14.7%
2.73%
+70.8%
CI NewCIGNA CORP NEW$25,422,00096,470
+100.0%
2.56%
LLY NewLILLY ELI & CO$22,900,00070,630
+100.0%
2.30%
BSX NewBOSTON SCIENTIFIC CORPcall$18,635,000500,000
+100.0%
1.87%
SGEN NewSEAGEN INC$18,235,000103,060
+100.0%
1.83%
A NewAGILENT TECHNOLOGIES INC$16,424,000138,280
+100.0%
1.65%
ISRG NewINTUITIVE SURGICAL INC$14,549,00072,490
+100.0%
1.46%
KZR NewKEZAR LIFE SCIENCES INC$10,006,0001,209,880
+100.0%
1.01%
ZBH NewZIMMER BIOMET HOLDINGS INC$7,566,00072,020
+100.0%
0.76%
IBB BuyISHARES TRishares biotech$6,345,000
+72.6%
53,940
+91.1%
0.64%
+160.4%
BuyHYPERFINE INC$6,131,000
-1.0%
2,749,400
+57.1%
0.62%
+49.2%
DXCM NewDEXCOM INC$5,573,00074,780
+100.0%
0.56%
XLV NewSELECT SECTOR SPDR TRsbi healthcare$4,438,00034,610
+100.0%
0.45%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$3,757,000499,640
+100.0%
0.38%
GLPG BuyGALAPAGOS NVspon adr$3,085,000
+109.6%
55,280
+132.9%
0.31%
+216.3%
MRUS BuyMERUS N V$2,699,000
-8.7%
119,200
+6.7%
0.27%
+37.6%
BCRX BuyBIOCRYST PHARMACEUTICALS INC$2,537,000
-31.7%
239,820
+5.0%
0.26%
+2.8%
CCXI NewCHEMOCENTRYX INCcall$2,478,000100,000
+100.0%
0.25%
ALGN NewALIGN TECHNOLOGY INCcall$2,367,00010,000
+100.0%
0.24%
PODD NewINSULET CORP$1,558,0007,150
+100.0%
0.16%
GERN BuyGERON CORP$1,550,000
+26.6%
1,000,000
+11.1%
0.16%
+90.2%
ITCI BuyINTRA-CELLULAR THERAPIES INC$1,545,000
+86.1%
27,070
+99.5%
0.16%
+181.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HCA HOLDINGS INC27Q1 20226.2%
ZIMMER HLDGS INC26Q2 20229.3%
DANAHER CORPORATION26Q3 20225.6%
NEUROCRINE BIOSCIENCES INC26Q4 20227.8%
UNITEDHEALTH GROUP INC24Q3 20226.4%
VERTEX PHARMACEUTICALS INC24Q3 20215.3%
HUMANA INC22Q3 20226.6%
BRISTOL-MYERS SQUIBB CO22Q3 20229.2%
BIOGEN INC21Q3 20228.5%
LABORATORY CORP AMER HLDGS20Q2 20208.3%

View HealthCor Management, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
HealthCor Management, L.P. Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CareView Communications IncMay 26, 2023186,970,00032.0%
Research Alliance Corp. IISold outFebruary 14, 202300.0%
ARYA Sciences Acquisition Corp IVSold outFebruary 14, 202200.0%
Aurinia Pharmaceuticals Inc.Sold outFebruary 14, 202200.0%
MADRIGAL PHARMACEUTICALS, INC.Sold outFebruary 14, 202200.0%
Medicus Sciences Acquisition Corp.Sold outFebruary 14, 202200.0%
Arcturus Therapeutics Holdings Inc.Sold outFebruary 12, 202100.0%
Intersect ENT, Inc.Sold outFebruary 12, 202100.0%
NEVRO CORPFebruary 12, 2021156,0460.5%
ViewRay, Inc.Sold outFebruary 12, 202100.0%

View HealthCor Management, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
42023-05-26
42023-05-26
SC 13D/A2023-05-26
42023-04-04
42023-04-04
SC 13D/A2023-04-03
13F-HR2023-02-15
SC 13G/A2023-02-14
42023-01-04
42023-01-04

View HealthCor Management, L.P.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (995103000.0 != 995101000.0)

Export HealthCor Management, L.P.'s holdings